Robitussin manufacturer Haleon has recalled eight lots of its cough syrups due to microbial contamination that could cause severe or life-threatening fungal infections in immunocompromised individuals, according to a statement posted by the Food and Drug Administration (FDA) on Wednesday1.
The recall affects six lots of Robitussin Honey CF Max Day Adult, 4 oz. and 8 oz., and two lots of Robitussin Honey CF Max NT Adult, 8 oz. The lot numbers and expiration dates of the recalled products are listed on the FDA website1. Consumers who have purchased these products are advised to stop using them immediately and contact Haleon for instructions on how to return them.
Haleon said that most users are unlikely to experience a serious health problem from the contaminated products, but an infection that may require medical intervention cannot be completely ruled out. The company said that the use of the affected products by immunocompromised individuals, such as those with HIV, cancer, or organ transplants, could potentially result in severe or life-threatening adverse events such as fungemia or disseminated fungal infection1.
Robitussin is widely used to relieve symptoms that come with cold, flu, hay fever or other respiratory allergies. Haleon said that there have been no reports of adverse events related to this recall so far. The company said that it is notifying distributors and customers directly of the microbial contamination and is working with the FDA to resolve the issue.
Consumers who have questions about the recall can call Haleon at (800) 245-1040 Monday through Friday, 8 a.m. to 6 p.m. Eastern time, or email mystory.us@haleon.com. Consumers who have experienced any problems related to the use of the recalled products should contact their healthcare providers and report them to the FDA1.
Post a Comment